Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Study aims to reduce C-section rates in pregnant women with obesity November 6, 2024 Night owls at higher risk of coronary artery calcification December 21, 2023 Neural connectivity predicts deep brain stimulation success in essential tremor December 1, 2024